Logo-apb

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by
Adv Pharm Bull. 2021;11(4): 618-623. doi: 10.34172/apb.2021.070
PMID: 34888208        PMCID: PMC8642801

Mini Review

DR-5 and DLL-4 mAb Functionalized SLNs of Gamma-Secretase Inhibitors- An Approach for TNBC Treatment

Mamta Kumari 1 ORCID, Praveen T. Krishnamurthy 1 * ORCID, Sai kiran S. S. Pinduprolu 1, Piyongsola Sola 1

Cited by CrossRef: 10

1- Choi H, Kim K. Theranostics for Triple-Negative Breast Cancer. Diagnostics. 2023;13(2):272 [Crossref]
2- Jiang N, Hu Y, Wang M, Zhao Z, Li M. The Notch Signaling Pathway Contributes to Angiogenesis and Tumor Immunity in Breast Cancer. BCTT. 2022;Volume 14:291 [Crossref]
3- Gummadi R, Dasari N, Kumar D, Pindiprolu S. Evaluating the Accuracy of Large Language Model (ChatGPT) in Providing Information on Metastatic Breast Cancer. Adv Pharm Bull. 2024;14(3):499 [Crossref]
4- Kumari M, Acharya A, Krishnamurthy P. Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics. Beilstein J Nanotechnol. 2023;14:912 [Crossref]
5- McHenry P, Prosperi J. Proteins Found in the Triple-Negative Breast Cancer Secretome and Their Therapeutic Potential. IJMS. 2023;24(3):2100 [Crossref]
6- Marracino L, Fortini F, Bouhamida E, Camponogara F, Severi P, Mazzoni E, Patergnani S, D’Aniello E, Campana R, Pinton P, Martini F, Tognon M, Campo G, Ferrari R, Vieceli Dalla Sega F, Rizzo P. Adding a “Notch” to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach. Front Cell Dev Biol. 2021;9 [Crossref]
7- Garg G, Garg S, Patel P, Gupta G, Kurmi B. Advances in solid-lipid nanoparticle chemistry as drug delivery vehicles. International Journal of Polymeric Materials and Polymeric Biomaterials. 2025;74(6):523 [Crossref]
8- Li J, Goh E, He J, Li Y, Fan Z, Yu Z, Yuan P, Liu D. Emerging Intrinsic Therapeutic Targets for Metastatic Breast Cancer. Biology. 2023;12(5):697 [Crossref]
9- Marques A, Costa P, Velho S, Amaral M. Lipid Nanoparticles Functionalized with Antibodies for Anticancer Drug Therapy. Pharmaceutics. 2023;15(1):216 [Crossref]
10- Roy N, Kumari M, Alam K, Bhattacharya A, Kaity S, Kaur K, Ravichandiran V, Roy S. Development of bioengineered 3D patient derived breast cancer organoid model focusing dynamic fibroblast–stem cell reciprocity. Prog Biomed Eng. 2025;7(1):012007 [Crossref]
11- Feng M, Santhanam R, Xing H, Zhou M, Jia H. Inhibition of γ-secretase/Notch pathway as a potential therapy for reversing cancer drug resistance. Biochemical Pharmacology. 2024;220:115991 [Crossref]
12- Kumari M, Kumari P, Ravi Naik M, Singh Rathore H, Kumar Shukla A, Iqbal Dar A, Ravi Kiran A, Kumari K, Acharya A, Thaggikuppe Krishnamurthy P. Targeted delivery of DAPT using dual antibody functionalized solid lipid nanoparticles for enhanced anti-tumour activity against triple negative breast cancer. International Journal of Pharmaceutics. 2025;670:125142 [Crossref]
13- Yang R, Li Y, Wang H, Qin T, Yin X, Ma X. Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapy. Mol Biomed. 2022;3(1) [Crossref]